Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Spectral AI ( (MDAI) ) just unveiled an update.
On January 5, 2026, Spectral AI announced that Colin Bristow resigned from its Board of Directors, with the resignation taking effect immediately. The company stated that Bristow’s departure did not arise from any disagreement regarding Spectral AI’s operations, policies, or practices, suggesting the move is not expected to signal underlying governance or strategic conflicts for stakeholders.
The most recent analyst rating on (MDAI) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Spectral AI stock, see the MDAI Stock Forecast page.
Spark’s Take on MDAI Stock
According to Spark, TipRanks’ AI Analyst, MDAI is a Neutral.
The score is held down primarily by weak financial performance (revenue contraction, sizable losses, negative equity, and ongoing cash burn). Technicals add pressure as the stock trades below key moving averages with negative MACD. Valuation is difficult to support with losses and no dividend, while the earnings call provides only partial offset via liquidity and FDA progress amid reduced guidance and higher losses.
To see Spark’s full report on MDAI stock, click here.
More about Spectral AI
Average Trading Volume: 530,343
Technical Sentiment Signal: Sell
Current Market Cap: $48.8M
Learn more about MDAI stock on TipRanks’ Stock Analysis page.